Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 1484
TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134635(CHEMBL3746329 | US9637484, 3)
Affinity DataIC50:  19nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134637(CHEMBL3746480 | US9637484, 2)
Affinity DataIC50:  61nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134675(CHEMBL3747573 | US9637484, 22)
Affinity DataIC50:  115nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134634(CHEMBL3745847 | US9637484, 31)
Affinity DataIC50:  129nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134670(CHEMBL3745776 | US9637484, 7)
Affinity DataIC50:  159nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM326044(1-((6-(2-methoxy-2-oxoethoxy)quinolin-4-yl)thio)cy...)
Affinity DataIC50:  164nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134644(CHEMBL3746658 | US9637484, 9)
Affinity DataIC50:  197nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134645(CHEMBL3746426 | US9637484, 5)
Affinity DataIC50:  207nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134665(CHEMBL3747343 | US9637484, 1)
Affinity DataIC50:  251nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134633(CHEMBL3747024 | US9637484, 33)
Affinity DataIC50:  324nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134671(CHEMBL3745813 | US9637484, 6)
Affinity DataIC50:  332nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134659(CHEMBL3746049 | US9637484, 4)
Affinity DataIC50:  343nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134638(CHEMBL3746315 | US9637484, 30)
Affinity DataIC50:  343nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134677(CHEMBL3747526 | US9637484, 32)
Affinity DataIC50:  352nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134674(CHEMBL3747747 | US9637484, 8)
Affinity DataIC50:  359nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134662(CHEMBL3747493 | US9637484, 17)
Affinity DataIC50:  398nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134639(CHEMBL3746433 | US9637484, 12)
Affinity DataIC50:  557nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134636(CHEMBL3747353 | US9637484, 23)
Affinity DataIC50:  658nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134646(CHEMBL3746317 | US9637484, 24)
Affinity DataIC50:  680nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent


TargetSolute carrier family 22 member 12(Human)
Shanghai Hengrui Pharmaceutical

US Patent
LigandPNGBDBM50134676(CHEMBL3747094 | US9637484, 10)
Affinity DataIC50:  926nMAssay Description:In vitro URAT1 assay can be used to identify compounds having potential activity for decreasing serum uric acid. In a suitable test, the vectors that...More data for this Ligand-Target Pair
In DepthDetails US Patent